Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Francine
View:
Post by boozehound3 on Aug 31, 2020 7:44am

Francine

Hopefully you sold last week when you got the news
Comment by 3burtc on Aug 31, 2020 7:55am
Stick a fork in it........
Comment by Francine01 on Aug 31, 2020 10:15am
Indeed sad morning. I still do believe that Capre works because 38.4% HTG after 26 weeks, is not the act god.  The only information that we have is primary end point 12 weeks.  This morning, we have 0 information, the placebo 17,9% reduction. Is it the average of weeks -2, -1 and 0 or at week 0 ?  They didn't not control the enrolment background and patients were not ...more  
Comment by SunsetGrill on Aug 31, 2020 10:35am
Francine - You are absolutly lost - you deserve to loose your shirt - I called you out months ago when you were talking out of both sides of your mouth. ANd while I hate to see anyone loose I have to say the way you strung people along on this board with "insider information" was deplorable The company tells you they drug does not work - the market tells you the same and you still have ...more  
Comment by Francine01 on Aug 31, 2020 11:09am
Just to be clear since accusation were made. I don't have any contact with management since shareholders meeting in august were i was asked questions. obvisoulsy, I didn't have any clue of this outcome. If so, I would have sold in december 2019. 
Acasti Pharma Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities